Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center - Report - MDSpire

Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease: A Retrospective Study from a Tertiary Care Center

  • By

  • Thomas Sheehan

  • Cormac Hegarty

  • Roisin Connaughton

  • Barry Hall

  • Orlaith B. Kelly

  • April 1, 2026

  • 0 min

Share

Clinical Report: Integrating Double-Balloon Enteroscopy into the Diagnostic Pathway for Suspected Small Bowel Crohn’s Disease

Overview

This study evaluates the integration of double-balloon enteroscopy (DBE) into the diagnostic pathway for suspected small bowel Crohn’s disease, highlighting the diagnostic yield of small bowel capsule endoscopy (SBCE) and factors influencing DBE referral. The findings suggest that SBCE is effective for initial assessment, while DBE is reserved for cases requiring further histological confirmation.

Background

Small bowel Crohn’s disease poses diagnostic challenges, often leading to delayed treatment. SBCE offers a non-invasive means to visualize the small bowel, but lacks the ability to obtain histological samples. DBE serves as a complementary tool, enabling direct assessment and therapeutic interventions, thus improving patient management in suspected cases of Crohn’s disease.

Data Highlights

OutcomeResult
SBCE performed as initial investigation90.8%
Direct DBE for therapeutic/histological reasons5.5%
SBCE-to-DBE conversion rate30.4%
SBCE diagnostic yield for inflammatory bowel disease70%
DBE confirmed Crohn’s disease21%
DBE excluded Crohn’s disease79%

Key Findings

  • SBCE established or excluded inflammatory bowel disease in 70% of patients.
  • DBE confirmed Crohn’s disease in 21% of patients referred after SBCE.
  • Increasing age and diagnostic uncertainty on SBCE were significant predictors for DBE referral.
  • The SBCE-to-DBE conversion rate was 30.4%.
  • DBE should be reserved for cases requiring histological confirmation or therapeutic intervention.

Clinical Implications

Clinicians should consider SBCE as the first-line diagnostic tool for suspected small bowel Crohn’s disease due to its high diagnostic yield. DBE is indicated for patients with uncertain SBCE findings or those needing histological confirmation, thereby optimizing patient management and minimizing unnecessary procedures.

Conclusion

The integration of SBCE and DBE enhances the diagnostic pathway for small bowel Crohn’s disease, allowing for effective triage and targeted interventions. This approach may lead to improved patient outcomes through timely diagnosis and treatment.

References

  1. Journal of Gastroenterology, 2020 -- Assessing Objective Targets for Treatment in Crohn's Disease
  2. Journal of Gastroenterology, 2018 -- Nationwide Case-Control Study on the Role of Capsule Endoscopy in Diagnosing Crohn’s Disease
  3. Journal of Gastroenterology, 2023 -- Prospective Multicenter Study on the Safety and Effectiveness of Capsule Endoscopy for Crohn’s Disease in Japan (SPREAD-J Study)
  4. Surgical Endoscopy, 2022 -- Prospective Cross-Sectional Study on Early Endoscopic Assessment of Rectal Anastomoses Post-Surgery
  5. ESGE Guidelines, 2022 -- Guidelines on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease
  6. ECCO-ESGAR-ESP-IBUS Guideline, 2023 -- Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2
  7. ESGE Guidelines on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease
  8. ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease
  9. https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/s12876-023-02839-8.pdf

Original Source(s)

Related Content